May 02, 2023 / 02:30PM GMT
Ed Arce - H. C. Wainwright & Co., LLC - Analyst
Great. Well, we'll get started. Our next presenting company is Galectin Therapeutics. And joining us is the President and CEO, Joel Lewis; as well as Pol Boudes, the Chief Commercial Officer -- sorry, Medical Officer.
Joel Lewis - Galectin Therapeutics Inc. - CEO & President
He can be the Chief Commercial Officer too.
Ed Arce - H. C. Wainwright & Co., LLC - Analyst
Good, good. Welcome, both of you.
Joel Lewis - Galectin Therapeutics Inc. - CEO & President
Thank you.
Pol Boudes - Galectin Therapeutics Inc. - Chief Medical Officer
Welcome.
Ed Arce - H. C. Wainwright & Co., LLC - Analyst
So I wanted to start if you could just briefly introduce the company and its strategy.
Joel Lewis - Galectin Therapeutics Inc. - CEO & President
Sure. First of all, thank you to Ed and H.C.
Galectin Therapeutics Inc at H.C. Wainwright BioConnect Investor Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot